BUSINESS DEVELOPMENT

The discovery capabilities in today’s biotech and pharma companies have yielded a large number of promising early stage anti-cancer compounds. In fact, both at an industry level and specific to many biotechnology and pharmaceutical companies, discovery technologies have yielded a number of compounds that exceed development capacity.

Clovis is focused on partnering with discovery-based companies and taking responsibility for developing and commercializing innovative products that may ultimately provide significant benefit to cancer patients.

Clovis is committed to oncology development, specifically, moving novel, targeted anti-cancer therapies through development and to the market in indications where significant unmet medical need exists or in subset patient populations where the compound may have significant promise.

If you would like additional information on partnering with us, or to discuss a compound currently in clinical development, please contact our business development team via email at businessdevelopment@clovisoncology.com